GLP-1 · GIP dual agonist
Tirzepatide in Canada
Tirzepatide is the dual-agonist research peptide — it activates both the GLP-1 and GIP receptors, the same molecule marketed under the brand names Mounjaro and Zepbound as a prescription medicine. Canada Peptides carries research-grade tirzepatide, priced and shipped in CAD. Everything below is for research and educational use only.
Tirzepatide — for sale
What is tirzepatide?
Tirzepatide is a dual agonist — it engages both the GLP-1 and GIP receptors on a single peptide backbone. Adding the GIP arm to the GLP-1 axis is what sets it apart from single-agonist compounds. For the full mechanism, see the tirzepatide research overview.
Tirzepatide, Mounjaro, and Zepbound
Mounjaro and Zepbound are brand names under which tirzepatide is marketed as a prescription medicine. The material sold here is research-grade tirzepatide, supplied strictly for laboratory research use — it is not the branded pharmaceutical and is not for human use.
Tirzepatide vs semaglutide and retatrutide
By receptor coverage: semaglutide is a single GLP-1 agonist, tirzepatide is a dual GLP-1/GIP agonist, and retatrutide is a triple GLP-1/GIP/glucagon agonist. The GLP-1 receptor agonists comparison breaks down how the three differ mechanistically.
Dosing in research
Published tirzepatide protocols use once-weekly subcutaneous administration with gradual titration. Our dosing-math and reconstitution guides cover the handling math. This is research context only — not a dosing recommendation for human use.
How to get tirzepatide in Canada
Research-grade tirzepatide is available to order on this page, shipped within Canada in CAD for research use only. Reconstitution and handling guidance is linked above.
Further reading
Semaglutide vs Tirzepatide — compared
Semaglutide vs tirzepatide compared on mechanism, half-life, and the head-to-head trial data from SURPASS-2 and SURMOUNT-5 — including where the cardiovascular evidence still diverges.
Tirzepatide dosage — research dosing notes
A literature overview of tirzepatide dosage: the 2.5 mg initiation step, four-week titration cadence, and 5/10/15 mg maintenance levels used in the trials, the ~5-day half-life behind once-weekly dosing, and reconstitution math for lyophilized vials. Research context only, not medical advice.
Tirzepatide Dosing: A Research Reference
How tirzepatide is dosed in published research — once-weekly administration, titration, and reconstitution math. Research use only, not medical advice.
Tirzepatide Side Effects: What the Research Reports
What the published literature reports about tirzepatide's tolerability and side-effect profile, framed for research. Research use only, not medical advice.
Is Tirzepatide the Same as Mounjaro? Tirzepatide vs Mounjaro & Zepbound
Tirzepatide vs Mounjaro — the difference between a compound and its brand names. Mounjaro and Zepbound are tirzepatide; what research-grade tirzepatide is and isn't. Research use only.
GLP-1 receptor agonists compared
Semaglutide vs Tirzepatide vs Retatrutide—mechanism, half-life, dosing, and the evidence gap.
Tirzepatide FAQ
- Is tirzepatide for sale in Canada?
- Yes. Research-grade tirzepatide is available in Canada from Canada Peptides, priced and shipped in CAD. It is supplied strictly for laboratory and research use.
- How can I get tirzepatide in Canada?
- You can order research-grade tirzepatide directly on this page. It ships within Canada in CAD, for research use only.
- Is tirzepatide the same as Mounjaro or Zepbound?
- Mounjaro and Zepbound are brand names under which tirzepatide is marketed as a prescription medicine. The material sold here is research-grade tirzepatide supplied strictly for laboratory research use — it is not the branded pharmaceutical and is not for human use.
- What is tirzepatide?
- Tirzepatide is a dual agonist: it activates both the GLP-1 and GIP receptors on a single peptide backbone. That dual coverage is what distinguishes it from single-agonist GLP-1 compounds.
- Tirzepatide vs semaglutide vs retatrutide — what's the difference?
- By receptor coverage: semaglutide is a single GLP-1 agonist, tirzepatide is a dual GLP-1/GIP agonist, and retatrutide is a triple GLP-1/GIP/glucagon agonist. See the GLP-1 receptor agonists comparison for how they differ.
- Is tirzepatide research use only?
- Yes. The tirzepatide sold here is supplied strictly for laboratory and research use. Nothing on this page is medical advice or a therapeutic claim.
Research & educational use only. This page is informational and does not constitute medical advice or a therapeutic claim.